Organon Receives Buyout Interest from Sun Pharma and Grünenthal
Organon (OGN) shares rose approximately 6% in premarket trading after reports indicated that Sun Pharmaceutical Industries Ltd. and Grünenthal are competing to acquire the U.S.-based women’s healthcare company. The potential acquisition has sparked investor interest and could lead to significant changes in the company's ownership structure.
Topics: Grünenthal Mergers and Acquisitions Organon Sun Pharmaceutical Industries Ltd. Women's Healthcare